Le Lézard
Classified in: Health, Science and technology, Business
Subject: STOCK/OTHER MARKET NEWS

3D Signatures Announces Close of Private Placement With Strategic Partner and Prospectus Update




These press releases may also interest you

at 20:08
GRAPEVINE, Texas, Oct. 23, 2017 /PRNewswire/ -- Support raised through Get in the Game, a luncheon aimed at increasing awareness of domestic violence resources available in North Texas, will assist The Gatehouse, a community supporting domestic...

at 19:43
NASHVILLE, Tenn., Oct. 23, 2017 /PRNewswire/ -- HealthCombix, a global decentralized healthcare development company, announced today Mr. Matthew Conboy has joined the company Advisory Board.   Mr. Conboy is a health care professional with a...

at 17:44
MILWAUKEE, Oct. 23, 2017 /PRNewswire-USNewswire/ -- Of the 981 physicians in the state of Wisconsin selected for the Best Doctors in America® 2017-2018 list, nearly two-thirds are Medical College of Wisconsin (MCW) faculty physicians and/or alumni....

at 17:30
NEW YORK, Oct. 23, 2017 /PRNewswire/ -- Lighthouse Guild, the leading not-for profit vision and healthcare organization, honored two scientists for their significant achievements in vision research at the 2017 Alfred W. Bressler Vision Science...

at 16:58
SAN FRANCISCO, Oct. 23, 2017 /PRNewswire/ -- Quest Diagnostics employees and executives joined more than 100 community volunteers at the National AIDS Memorial to announce a $100,000 grant to bolster the memorial's volunteer workday program in 2018....

at 16:57
SAN DIEGO, Oct. 23, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that valbenazine, a novel selective vesicular monoamine transporter 2 (VMAT2), has been granted Orphan Drug Designation by the U.S. Food and Drug...




News published on 4 october 2017 at 18:33 and distributed by: